Story perspectives

FDA Turmoil: Top Regulator Resigns Amid Allegations

11/4/2025

31 3

Summary

Story summary

The FDA faces internal turmoil and employee dissatisfaction under Secretary Robert F. Kennedy Jr., prompting departures.
George Tidmarsh, the agency's top drug regulator, resigned amid misconduct allegations, creating staffing challenges.
Tidmarsh says he was retaliated against for opposing a fast-track drug approval plan.
Analysts warn the FDA's drug approval rate lags, risking public health.
Health and Human Services says the agency operates on science, despite concerns about integrity.

1 of 1

Story summary

The FDA faces internal turmoil and employee dissatisfaction under Secretary Robert F. Kennedy Jr., prompting departures.
George Tidmarsh, the agency's top drug regulator, resigned amid misconduct allegations, creating staffing challenges.
Tidmarsh says he was retaliated against for opposing a fast-track drug approval plan.
Analysts warn the FDA's drug approval rate lags, risking public health.
Health and Human Services says the agency operates on science, despite concerns about integrity.